---
company: CareCloud, Inc.
ticker: CCLD
form: 8-K
filed: 2026-05-07
accession: 0001493152-26-021603
source: https://www.sec.gov/Archives/edgar/data/1582982/000149315226021603/
---

# CareCloud (CCLD) earnings release, May 7, 2026

CareCloud, Inc. (CCLD) · Form 8-K, Item 2.02 · Filed 2026-05-07 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1582982/000149315226021603/)

Exhibit

99.1

NASDAQ:

CCLD | CCLDO

CareCloud

Reports Q1 2026 Results

Reaffirms

Guidance Following Capital Structure Simplification; Revenue Grows 13% Year-Over-Year

SOMERSET,

N.J., May 7, 2026 (GLOBE NEWSWIRE)— CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, today announced financial results for the quarter ended March 31, 2026. The Company reaffirmed its previously issued financial guidance following the successful closing of a $50 million credit facility, the announced redemption of 100% of its Series B Preferred Stock, and AI product launches. Together, these milestones mark a pivotal step in CareCloud’s ongoing growth trajectory—positioning the Company to scale its AI-driven revenue and expand margins, reporting its eighth consecutive quarter of positive GAAP net income with a meaningfully simpler capital structure for the future.

First

Quarter 2026 Financial Highlights:

Recent

Accomplishments

Management

Commentary

“Q1

2026 marks the start of an exciting new chapter for CareCloud. We delivered 13% year-over-year revenue growth, expanded our AI offering and our addressable market into the inpatient segment, and took decisive action to simplify our capital structure with the announced full redemption of our Series B Preferred Stock and the closing of a new $50 million credit facility. With the Medsphere integration substantially complete, a stronger balance sheet, and our 2026 guidance reaffirmed, we believe CareCloud is uniquely positioned to translate this momentum into accelerating, durable shareholder value through the balance of 2026 and beyond.” — Stephen Snyder, Chief Executive Officer, CareCloud

“This was the quarter our AI strategy moved from promise to performance. stratusAI Desk Agent is now resolving approximately 75% of inbound patient calls autonomously, stratusAI Voice Audit is surfacing revenue and compliance opportunities in real time, and our newly launched

AI Center of Excellence is shipping new agentic capabilities at an accelerating pace. By layering these AI services on top of our expanded ambulatory and inpatient platform—including our #1 Black Book–ranked EDIS—we are building a differentiated, full-stack healthcare technology offering that scales with every customer we serve and creates a durable, technology-led competitive advantage.” — A. Hadi Chaudhry, Chief Strategy Officer, CareCloud

“We are reaffirming our 2026 guidance based on our confidence for the year. The integration of our Medsphere acquisition impacted our earnings as anticipated this quarter and is now substantially complete, positioning us to deliver improving margins through the balance of 2026.

We look forward to redeeming all of our Series B Preferred Stock for cash on May 15.” — Norman Roth, Interim Chief Financial Officer and Corporate Controller, CareCloud

2026

Outlook

CareCloud entered 2026 with significant operating momentum and is reaffirming its guidance for calendar year 2026.

Revenue guidance is based on management’s expectations for contributions from existing clients, together with cross-selling and other organic and inorganic growth. EPS guidance of $0.20–$0.23 represents a 100-130% increase from the $0.10 achieved in full year 2025. Adjusted

EBITDA guidance is $29–$31 million compared to the 2025 amount of $27.5 million.

As anticipated, Q1 2026 GAAP net income reflects a temporary, near-term impact from elevated amortization of acquired intangible assets and one-time integration costs tied to the Medsphere acquisition (which closed August 2025) and our other 2025 acquisitions. Q1 2026 adjusted EBITDA was depressed due to transition costs from Medsphere which have largely been eliminated by the end of Q1, so they will have a decreasing impact in future quarters. These items are non-recurring and integration-related, are expected to subside as the integrations are completed, and are not indicative of the underlying earnings power of the business. Management expects margin expansion to resume as we move through 2026, consistent with the full-year guidance reaffirmed above.

Conference

Call Information

CareCloud management will host a live conference call today, May 7, 2026, at

8:30 a.m. Eastern Time to discuss first quarter 2026 results and the Company’s 2026 strategy.

Webcast: ir.carecloud.com/events

Dial-in

(Audio Only):

646-307-1865 | Reference: “CareCloud, Inc. First Quarter 2026 Results Conference Call.”

Replay

Dial-in:

412-317-6671 | Access Code: 1116667 (available approximately 3 hours after the call).

About

CareCloud

CareCloud brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 45,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at carecloud.com.

Follow

CareCloud on

LinkedIn,

X and

Facebook.

For additional information, please visit our website at carecloud.com. To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com.

Contacts

Use of Non-GAAP Financial Measures

In our earnings releases, prepared remarks, conference calls, slide presentations and webcasts, we use and discuss non-GAAP financial measures,... (truncated)asure most directly comparable to each non-GAAP financial measure used or discussed and a reconciliation of the differences between each non-GAAP financial measure and the comparable GAAP financial measure, are included in this press release after the condensed consolidated financial statements. Our earnings press releases containing such non-GAAP reconciliations can be found in the Investor Relations section of our web site at i r.carecloud.com.

Forward-Looking

Statements

This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities

Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,”

“will,” “shall,” “should,” “could,” “intends,” “expects,” “plans,”

“goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,”

“forecasts,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.

Our operations involve risks and uncertainties, many of which are outside our control and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct.

Forward-looking statements in this press release include, without limitation, statements reflecting management’s expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, and the expected results from the integration of our acquisitions.

These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, manage and keep our information systems secure and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange

Commission.

The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.

CARECLOUD,

INC.

## Financial statements

### Income Statement (For the Fiscal Year Ending December 31, 2026 — CareCloud entered 2026 with significant operating momentum and is reaffirming its guidance for calendar year 2026.)

| | For the Fiscal Year Ending December 31, 2026 – Full Year 2026 Guidance |
|---|---:|
| Revenue | $128 – $132 million |
| Adjusted EBITDA | $29 – $31 million |
| GAAP Net Income Per Share (EPS) | $0.20 – $0.23 |

### Income Statement (Three Months Ended — ($ in thousands, except share and per share amounts))

| | Three Months Ended – March 31, – 2026 | Three Months Ended – March 31, – 2025 |
|---|---:|---:|
| NET REVENUE | 31,270 | 27,632 |
| OPERATING EXPENSES: | Direct operating costs | 16,850 | 15,464 |
| OPERATING EXPENSES: | Selling and marketing | 1,414 | 1,131 |
| OPERATING EXPENSES: | General and administrative | 5,496 | 4,332 |
| OPERATING EXPENSES: | Research and development | 2,416 | 1,235 |
| OPERATING EXPENSES: | Change in contingent consideration | 57 |  |
| OPERATING EXPENSES: | Depreciation and amortization | 4,037 | 3,337 |
| OPERATING EXPENSES: | Restructuring costs |  | 114 |
| OPERATING EXPENSES: | Total operating expenses | 30,270 | 25,613 |
| OPERATING EXPENSES: | OPERATING INCOME | 1,000 | 2,019 |
| OTHER: | Interest income | 10 | 42 |
| OTHER: | Interest expense | -58 | -58 |
| OTHER: | Other income (expense) - net | 22 | -14 |
| OTHER: | INCOME BEFORE PROVISION FOR INCOME TAXES | 974 | 1,989 |
| OTHER: | Income tax provision | 52 | 41 |
| OTHER: | NET INCOME | 922 | 1,948 |
| OTHER: | Preferred stock dividend | 1,365 | 2,811 |
| OTHER: | NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS | -443 | -863 |
| OTHER: | Net loss per common share: basic and diluted | -0.01 | -0.04 |
| OTHER: | Weighted-average common shares used to compute basic and diluted loss per share | 42,471,949 | 23,813,943 |

### Income Statement (Three Months Ended March 31, — Set forth below is a reconciliation of our “adjusted EBITDA” to our GAAP net income. (in thousands))

| | Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 |
|---|---:|---:|
| Net revenue | 31,270 | 27,632 |
| GAAP net income | 922 | 1,948 |
| Provision for income taxes | 52 | 41 |
| Net interest expense | 48 | 16 |
| Foreign exchange loss / other expense | 32 | 19 |
| Stock-based compensation expense | 64 | 108 |
| Depreciation and amortization | 4,037 | 3,337 |
| Change in contingent consideration | 57 |  |
| Transaction and integration costs | 158 | 12 |
| Restructuring costs |  | 114 |
| Adjusted EBITDA | 5,370 | 5,595 |

### Income Statement (Three Months Ended March 31,)

| | Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 |
|---|---:|---:|
| GAAP net loss attributable to common shareholders, per share | -0.01 | -0.04 |
| Impact of preferred stock dividend | 0.03 | 0.09 |
| Net income per end-of-period share | 0.02 | 0.05 |
| Foreign exchange loss / other expense | 0 | 0 |
| Stock-based compensation expense | 0 | 0 |
| Amortization of purchased intangible assets | 0.02 | 0 |
| Change in contingent consideration | 0 |  |
| Transaction and integration costs | 0.01 | 0 |
| Restructuring costs |  | 0 |
| Non-GAAP adjusted earnings per share | 0.05 | 0.05 |
| End-of-period common shares | 42,492,949 | 42,321,129 |

### Balance Sheet (December 31, — ($ in thousands, except share and per share amounts))

| | March 31, – 2026 – (Unaudited) | December 31, – 2025 |
|---|---:|---:|
| Current assets: | Cash | 3,354 | 3,117 |
| Current assets: | Restricted cash | 500 | 500 |
| Current assets: | Accounts receivable - net | 15,236 | 15,062 |
| Current assets: | Contract asset | 3,502 | 3,664 |
| Current assets: | Inventory | 432 | 507 |
| Current assets: | Current assets - related party | 16 | 16 |
| Current assets: | Prepaid expenses and other current assets | 3,048 | 2,872 |
| Current assets: | Total current assets | 26,088 | 25,738 |
| Current assets: | Property and equipment - net | 7,461 | 7,775 |
| Current assets: | Operating lease right-of-use assets | 4,662 | 3,106 |
| Current assets: | Intangible assets - net | 16,500 | 18,968 |
| Current assets: | Goodwill | 31,435 | 31,442 |
| Current assets: | Other assets | 573 | 569 |
| Current assets: | TOTAL ASSETS | 86,719 | 87,598 |
| Current liabilities: | Accounts payable | 5,508 | 6,937 |
| Current liabilities: | Accrued compensation | 3,476 | 4,136 |
| Current liabilities: | Accrued expenses | 5,951 | 5,970 |
| Current liabilities: | Operating lease liability (current portion) | 1,358 | 927 |
| Current liabilities: | Deferred revenue (current portion) | 4,748 | 4,148 |
| Current liabilities: | Notes payable (current portion) | 742 | 728 |
| Current liabilities: | Contingent consideration (current portion) | 734 | 909 |
| Current liabilities: | Dividend payable | 944 | 668 |
| Current liabilities: | Total current liabilities | 23,461 | 24,423 |
| Current liabilities: | Notes payable | 250 | 441 |
| Current liabilities: | Contingent consideration | 400 | 232 |
| Current liabilities: | Operating lease liability | 3,390 | 2,187 |
| Current liabilities: | Deferred revenue | 891 | 809 |
| Current liabilities: | Total liabilities | 28,392 | 28,092 |
| SHAREHOLDERS’ EQUITY: | Preferred stock, $0.001 par value - authorized 7,000,000 shares. Series A, issued and outstanding 984,530 shares at March 31, 2026 and December 31, 2025. Series B, issued and outstanding 1,511,372 shares at March 31, 2026 and December 31, 2025. | 2 | 2 |
| SHAREHOLDERS’ EQUITY: | Common stock, $0.001 par value - authorized 85,000,000 shares. Issued 43,233,748 and 43,178,748 shares at March 31, 2026 and December 31, 2025, respectively. Outstanding 42,492,949 and 42,437,949 shares at March 31, 2026 and December 31, 2025, respectively. | 43 | 43 |
| SHAREHOLDERS’ EQUITY: | Additional paid-in capital | 117,807 | 119,936 |
| SHAREHOLDERS’ EQUITY: | Accumulated deficit | -54,910 | -55,832 |
| SHAREHOLDERS’ EQUITY: | Accumulated other comprehensive loss | -3,953 | -3,981 |
| SHAREHOLDERS’ EQUITY: | Less: 740,799 common shares held in treasury, at cost at March 31, 2026 and December 31, 2025 | -662 | -662 |
| SHAREHOLDERS’ EQUITY: | Total shareholders’ equity | 58,327 | 59,506 |
| SHAREHOLDERS’ EQUITY: | TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | 86,719 | 87,598 |

### Cash Flow (($ in thousands))

| | 2026 | 2025 |
|---|---:|---:|
| OPERATING ACTIVITIES: | Net income | 922 | 1,948 |

### Cash Flow (Three Months Ended March 31, — Set forth below is a reconciliation of our non-GAAP “free cash flow” to our GAAP net cash provided by operating activities. (in thousands))

| | Three Months Ended March 31, – 2026 | Three Months Ended March 31, – 2025 |
|---|---:|---:|
| Net cash provided by operating activities | 3,611 | 5,113 |
| Purchases of property and equipment | -412 | -624 |
| Capitalized software and other intangible assets | -820 | -846 |
| Free cash flow | 2,379 | 3,643 |
| Net cash used in investing activities 1 | -1,232 | -1,510 |
| Net cash used in financing activities | -2,150 | -1,932 |
